CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Todisco Joseph
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Lefkowitz Steven W
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Dillione Janet
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Kaplan Myron
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Stewart Robert A
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director DUNTON ALAN W
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director Duncan Gregory Scott
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Todisco Joseph
CorMedix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nomura Holdings, Inc.(5.4%),Nomura Global Financial Products, Inc.(5.4%)
CorMedix | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.15%)
CorMedix | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.4%)
CorMedix | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Masson-Hurlburt Elizabeth
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Masson-Hurlburt Elizabeth
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer David Matthew T
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Mistry Erin
CorMedix | 4: Statement of changes in beneficial ownership of securities-Officer Todisco Joseph
CorMedix | 4: Statement of changes in beneficial ownership of securities-Director DUNTON ALAN W
CorMedix | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Zelnick Kaufman Beth
CorMedix | 3: Initial statement of beneficial ownership of securities-Chief Legal Officer Zelnick Kaufman Beth
CorMedix | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Mistry Erin
No Data